Björnsson E, Kowalski A, Schröder R. "Method for the Synthesis of 1-(2-Fluoro-4-nitrophenyl)-1,4-diazepane" [P]. European Patent, EP 3144932 A1, 2024-06-26.
Lefèvre J P, Johansson L, Schröder R. "A Process for Preparing High-Purity 1-(2-Fluoro-4-nitrophenyl)-1,4-diazepane" [P]. European Patent, EP 3993949 A1, 2023-04-13.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2015, 2447, (6), 2559-2575.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2024, 1724, (4), 5237-5249.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of 1-(2-Fluoro-4-nitrophenyl)-1,4-diazepane Using HRMS and NMR". J. Nat. Prod., 2014, 1942, (12), 7675-7700.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2014, 337, 738-758.